FAX Capital Announces Addition of Marc Robinson to Board of Hamilton Thorne Ltd., a FAX portfolio investment

NOT FOR DISSEMINATION IN THE UNITED STATES OR DISTRIBUTION TO U.S. NEWS WIRE SERVICESTORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) — FAX Capital Corp. (the “Company”) (TSX: FXC and FXC.WT) is pleased to announce that Marc Robinson, the Company’s Managing Director, Investments, has been appointed to the board of directors of Hamilton Thorne Ltd. (TSXV: HTL) (“Hamilton Thorne”), effective January 19, 2021. The Company currently owns an 11.5% interest in Hamilton Thorne.“Hamilton Thorne is a high-quality business benefitting from durable competitive advantages, substantial long-term market tailwinds, multiple drivers of organic growth and a platform to execute M&A across a fragmented global market,” said Mr. Robinson. “I am looking forward to working alongside a proven management team and board to help Hamilton Thorne realize its significant potential.”“We are delighted to have Marc join our Board of Directors,” said David Wolf, Hamilton Thorne’s President and Chief Executive Officer. “As Hamilton Thorne continues to grow and evolve, it is important to add new voices and experience that will support our continued development over the next decade. We look forward to Marc’s advice and support as Hamilton Thorne continues growing its business.”The participation of Mr. Robinson on Hamilton Thorne’s board is consistent with the Company’s strategy to utilize its permanent capital to take significant ownership positions in high quality, well managed businesses and work proactively with them over the long term to deliver value.Hamilton Thorne is a Massachusetts-based manufacturer, marketer and distributor of equipment, precision instruments, consumables, software and services to the global Assisted Reproductive Technologies (ART) market. The company’s products, marketed under the Hamilton Thorne, Gynemed, Embryotech and Planer brands, are cleared for sale in the US, Europe, China, and Canada and are sold to a customer base that includes pharmaceutical and biotech companies, fertility clinics, research centres and others.About FAX Capital Corp.
The Company is an investment holding company with a business objective to maximize its intrinsic value on a per share basis over the long-term by seeking to achieve superior investment performance commensurate with reasonable risk. The Company intends to invest in equity, debt and/or hybrid securities of high-quality businesses. The Company initially intends to invest in approximately 10 to 15 high-quality small cap public and private businesses located primarily in Canada and, to a lesser extent, the United States. Further information about the Company is available at www.faxcapitalcorp.com.For additional information please contact:Investor Relations
Tim Foran
Email: IR@faxcapitalcorp.com
Media Relations
Kieran Lawler
Telephone: (416) 303-0799
Email: Kieran.lawler@loderockadvisors.comCautionary Note Regarding Forward-Looking InformationThis press release contains forward-looking information. Such forward-looking information or statements (FLS) are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes. Any such FLS may be identified by words such as “proposed”, “expects”, “intends”, “may”, “will”, and similar expressions. FLS contained or referred to in this press release includes, but is not limited to the Company’s outlook and future plans with respect to its investment in Hamilton Thorne, including its continuing representation on the board of directors of Hamilton Thorne; the future or expected performance of Hamilton Thorne and/or the Company’s other portfolio investments; the Company’s continuing investment thesis in respect of Hamilton Thorne and other portfolio investments; and the Company’s investment approach, objectives and strategy, including investment selection and pace of continued investment.FLS is based on a number of factors and assumptions which have been used to develop such statements and information, but which may prove to be incorrect. Although the Company believes that the expectations reflected in such FLS is reasonable, undue reliance should not be placed on FLS because the Company can give no assurance that such expectations will prove to be correct. Factors that could cause actual results to differ materially from those described in such FLS include, but are not limited to, the continued impact of coronavirus (COVID-19), as well as the identified risk factors included in the Company’s public disclosure, including the annual information form dated March 26, 2020, which is available on SEDAR at www.sedar.com and on the Company’s website at www.faxcapitalcorp.com. The FLS in this press release reflect the current expectations, assumptions, judgements and/or beliefs of the Company based on information currently available to the Company, and are subject to change without notice.Any FLS speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any FLS, whether as a result of new information, future events or results or otherwise. The FLS contained in this press release are expressly qualified by this cautionary statement. For more information on the Company, please review its continuous disclosure filings that are available at www.sedar.com.No securities regulatory authority has either approved or disapproved of the contents of this news release. The Toronto Stock Exchange accepts no responsibility for the adequacy or accuracy of this release.